daratumumab plus ibrutinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for daratumumab plus ibrutinib, covering 2023-10-23 to 2023-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia [Phase 2]